Singapore, Aug 17 (ANI): S&P Global Ratings said on Tuesday that Jubilant Pharma Ltd will remain integral to the broader group even after its proposed reorganisation.
Mumbai (Maharashtra) [India], July 30 (ANI): The proposed transfer of Jubilant Pharma Ltd's (JPL's) active pharmaceutical ingredients (API) business to its parent Jubilant Pharmova Ltd (JPHL) will not affect JPL's ratings, says Fitch Ratings.
Singapore, July 26 (ANI): Jubilant Pharma Ltd (JPL) will continue to maintain good rating headroom as the impact of a recent US Food and Drug Administration import alert for its generic formulations plant in India will be limited, Fitch Ratings has said.
Ahmedabad (Gujarat) [India]/ Yardley (Pennsylvania)/Hoschton (Georgia), November 6 (ANI/PRNewswire): Jubilant Pharma Ltd. and Aavis Pharmaceuticals Inc. announce the launch of Hydroxychloroquine Sulfate tablets, 200 mg, a therapeutic equivalent version of Plaquenil (hydroxychloroquine sulfat